ATE270277T1 - Anilide als vitamin-a-säure-mimetika - Google Patents

Anilide als vitamin-a-säure-mimetika

Info

Publication number
ATE270277T1
ATE270277T1 AT98965820T AT98965820T ATE270277T1 AT E270277 T1 ATE270277 T1 AT E270277T1 AT 98965820 T AT98965820 T AT 98965820T AT 98965820 T AT98965820 T AT 98965820T AT E270277 T1 ATE270277 T1 AT E270277T1
Authority
AT
Austria
Prior art keywords
anilides
vitamin
acid mimetics
mimetics
acid
Prior art date
Application number
AT98965820T
Other languages
English (en)
Inventor
Dominique Mabire
Christophe Denis Adelinet
Imre Christian Csoka
Marc Gaston Venet
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE270277T1 publication Critical patent/ATE270277T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98965820T 1997-12-11 1998-12-08 Anilide als vitamin-a-säure-mimetika ATE270277T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203886 1997-12-11
PCT/EP1998/008126 WO1999029674A1 (en) 1997-12-11 1998-12-08 Retinoic acid mimetic anilides

Publications (1)

Publication Number Publication Date
ATE270277T1 true ATE270277T1 (de) 2004-07-15

Family

ID=8229041

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98965820T ATE270277T1 (de) 1997-12-11 1998-12-08 Anilide als vitamin-a-säure-mimetika

Country Status (21)

Country Link
US (5) US6319939B1 (de)
EP (1) EP1037880B1 (de)
JP (1) JP2001525400A (de)
AR (1) AR017205A1 (de)
AT (1) ATE270277T1 (de)
AU (1) AU2160899A (de)
BG (1) BG104499A (de)
CA (1) CA2312720A1 (de)
DE (1) DE69824885T2 (de)
DK (1) DK1037880T3 (de)
ES (1) ES2224462T3 (de)
HU (1) HUP0100860A3 (de)
ID (1) ID21498A (de)
MY (1) MY129484A (de)
PL (1) PL341059A1 (de)
PT (1) PT1037880E (de)
SI (1) SI1037880T1 (de)
TR (1) TR200001645T2 (de)
TW (1) TW523503B (de)
WO (1) WO1999029674A1 (de)
ZA (1) ZA9811351B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1037880T3 (da) * 1997-12-11 2004-11-15 Janssen Pharmaceutica Nv Anilider som retinsyremimetika
DE19935219A1 (de) 1999-07-27 2001-02-01 Boehringer Ingelheim Pharma Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung
EP1232150B1 (de) * 1999-11-16 2007-10-10 Boehringer Ingelheim Pharmaceuticals Inc. Harnstoff derivate als entzündungshemmende mittel
US6667278B2 (en) 2000-12-05 2003-12-23 University Technologies International Inc. Non-steroidal mimetics of brassinolide
UA76977C2 (en) 2001-03-02 2006-10-16 Icos Corp Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
TWI239942B (en) * 2001-06-11 2005-09-21 Dainippon Pharmaceutical Co N-arylphenylacetamide derivative and pharmaceutical composition containing the same
EP1430042A2 (de) * 2001-09-25 2004-06-23 SmithKline Beecham Corporation Bicyclische heterocyclen als rxr-liganden
AR040241A1 (es) 2002-06-10 2005-03-23 Merck & Co Inc Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
AU2003265398A1 (en) * 2002-08-09 2004-02-25 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
US7351719B2 (en) 2002-10-31 2008-04-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
NZ546834A (en) * 2003-10-01 2010-03-26 Adolor Corp Spirocyclic heterocyclic derivatives and methods of their use
US20040259744A1 (en) * 2003-12-19 2004-12-23 Meidong Yang Skin and hair cleansers containing sulfur
US7592373B2 (en) 2003-12-23 2009-09-22 Boehringer Ingelheim International Gmbh Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
DE10360745A1 (de) * 2003-12-23 2005-07-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
IN2012DN03023A (de) 2004-01-26 2015-07-31 Merck Sharp & Dohme
DE102004017934A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
US7524862B2 (en) 2004-04-14 2009-04-28 Boehringer Ingelheim International Gmbh Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7964619B2 (en) * 2005-06-03 2011-06-21 The University Of North Carolina At Chapel Hill Teraryl components as antiparasitic agents
US8101636B2 (en) * 2005-06-03 2012-01-24 The University Of North Carolina At Chapel Hill Linear dicationic terphenyls and their aza analogues as antiparasitic agents
US7671221B2 (en) * 2005-12-28 2010-03-02 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
AU2006336504C9 (en) * 2005-12-28 2015-05-14 Vertex Pharmaceuticals Incorporated 1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
US7576207B2 (en) * 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
WO2008033299A2 (en) * 2006-09-12 2008-03-20 Adolor Corporation Use of n-containing spirocompounds for the enhancement of cognitive function
GB0720061D0 (en) * 2007-10-13 2007-11-21 Finnen Michael Method & composition for the treatment of acne and sebum dependent pilosebaceous disorders
US8546576B2 (en) * 2008-06-06 2013-10-01 Sk Biopharmaceuticals Co., Ltd. 3 or 4-substituted piperidine compounds
PE20141637A1 (es) 2011-04-28 2014-11-20 Japan Tobacco Inc Compuesto de amida y aplicacion farmaceutica para el mismo
WO2014089296A2 (en) * 2012-12-06 2014-06-12 Institute For Hepatitis And Virus Research Functionalized benzamide derivatives as antiviral agents against hbv infection
EP3514145A1 (de) * 2014-08-29 2019-07-24 Tokyo Ohka Kogyo Co., Ltd. Imidazolverbindung, metalloberflächenbehandlungsflüssigkeit, metalloberflächenbehandlungsverfahren und laminatherstellungsverfahren
US9638690B2 (en) 2014-11-07 2017-05-02 The University Of British Columbia Compounds and compositions for use as alkylating agent sensors and methods of use thereof
JP6533997B2 (ja) * 2014-12-26 2019-06-26 株式会社ヤクルト本社 Znf143阻害活性を有する化合物およびその利用
TW202136238A (zh) * 2020-01-06 2021-10-01 大陸商廣東東陽光藥業有限公司 RORγt抑制劑及其製備方法和用途
CN115515934B (zh) * 2020-02-07 2025-10-17 赛特凯恩蒂克公司 Nampt调节剂
CN117986139A (zh) * 2022-11-04 2024-05-07 深圳有为技术控股集团有限公司 一种1-(联苯基-4-基)-2-甲基-2-胺基丙烷-1-酮的合成方法
WO2024126777A1 (en) * 2022-12-16 2024-06-20 Astrazeneca Ab Heteroaromatic compounds
CN118791447A (zh) * 2023-04-13 2024-10-18 江苏吉贝尔药业股份有限公司 一种新型紫杉烷类化合物的制备方法、应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6032629B2 (ja) * 1976-01-01 1985-07-29 協和醗酵工業株式会社 新規なベンジルピリジン誘導体
ZA793186B (en) * 1978-07-06 1981-02-25 Duphar Int Res New urea and thiourea compounds, method of preparing the new compounds, as well as insecticidal compositions on the basis of these compounds
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
US4927839A (en) * 1979-03-07 1990-05-22 Imperial Chemical Industries Plc Method of preventing fungal attack on wood, hides, leather or paint films using a triazole
EP0307518B1 (de) 1984-06-08 1993-07-28 The Whitaker Corporation Faseroptischer Stecker hoher Präzision
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
US4788206A (en) * 1987-07-10 1988-11-29 Hoffmann-La Roche Inc. Pentadieneamides
CA2002864C (en) * 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
CA2002859C (en) 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
GB9511355D0 (en) 1995-06-06 1995-08-02 Fujisawa Pharmaceutical Co Urea derivatives
TW349948B (en) 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
CN1102593C (zh) 1996-06-27 2003-03-05 詹森药业有限公司 N-[4-(杂芳基甲基)苯基]-杂芳基胺类化合物
DK1037880T3 (da) * 1997-12-11 2004-11-15 Janssen Pharmaceutica Nv Anilider som retinsyremimetika
EP1232150B1 (de) * 1999-11-16 2007-10-10 Boehringer Ingelheim Pharmaceuticals Inc. Harnstoff derivate als entzündungshemmende mittel
US6667278B2 (en) * 2000-12-05 2003-12-23 University Technologies International Inc. Non-steroidal mimetics of brassinolide
FR2836277B1 (fr) 2002-02-19 2004-04-16 Alstom Mecanisme de commande a ressorts pour disjoncteur a mouvement rectiligne
NZ546834A (en) * 2003-10-01 2010-03-26 Adolor Corp Spirocyclic heterocyclic derivatives and methods of their use

Also Published As

Publication number Publication date
BG104499A (en) 2001-08-31
ZA9811351B (en) 2000-06-12
US20050165018A1 (en) 2005-07-28
WO1999029674A1 (en) 1999-06-17
MY129484A (en) 2007-04-30
PL341059A1 (en) 2001-03-26
AR017205A1 (es) 2001-08-22
TR200001645T2 (tr) 2000-12-21
US7179825B2 (en) 2007-02-20
US6936626B2 (en) 2005-08-30
ID21498A (id) 1999-06-17
US20070105858A1 (en) 2007-05-10
US7579352B2 (en) 2009-08-25
US20080058334A1 (en) 2008-03-06
AU2160899A (en) 1999-06-28
DK1037880T3 (da) 2004-11-15
JP2001525400A (ja) 2001-12-11
TW523503B (en) 2003-03-11
EP1037880B1 (de) 2004-06-30
US20020115653A1 (en) 2002-08-22
EP1037880A1 (de) 2000-09-27
HUP0100860A2 (hu) 2001-09-28
DE69824885D1 (de) 2004-08-05
PT1037880E (pt) 2004-11-30
ES2224462T3 (es) 2005-03-01
SI1037880T1 (en) 2004-10-31
HUP0100860A3 (en) 2003-03-28
DE69824885T2 (de) 2005-07-21
US6319939B1 (en) 2001-11-20
CA2312720A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
ATE270277T1 (de) Anilide als vitamin-a-säure-mimetika
DK0977733T3 (da) Arylsulfonylaminohydroxamsyrederivater
TR199802106A3 (tr) Sübstitüe edilmis izokinolin-3-karbon asidi amidleri.
DE69829356D1 (de) Anzeige
EP0932137A4 (de) Anzeigegerät
DE69820906D1 (de) Hydroxamsäure-derivate als matrix metalloproteinaseinhibitoren
DE69818280D1 (de) Homogenisierventil
ATE217912T1 (de) Hochverformbare, korrosionsbeständige al- legierung
FI973847A0 (fi) Anordning vid en skyddsanordning
TR199802625A3 (tr) Yeni farmasötikler
FI971898A0 (fi) Anordning vid en anestesievaporator
FI970925A0 (fi) Anordning vid anestesianlaeggningar
DE69833661D1 (de) Mühle
NO996520D0 (no) Opploeste sertralinblandinger
FI971744A0 (fi) Anordning vid cirkulationssmoerjningssystem
DK1051156T3 (da) Farmaceutiske præparater
DE59811318D1 (de) Anzeigeeinrichtung
DE69803558D1 (de) Bügelpresse
DE69514081D1 (de) Korrosionsbeständiger Federstahl
FR2766727B1 (fr) Exerciseur
FI973293A0 (fi) Arrangemang vid verktyg
NO971391D0 (no) Tredemölle
ATA35697A (de) Doppelkurbeltrieb
DK0969815T3 (da) Farmaceutiske præparater
SE9702958D0 (sv) Pharmaceuticals

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1037880

Country of ref document: EP